Haemodynamic effects of levosimendan in advanced but stable chronic heart failure
Clicks: 217
ID: 272406
2018
Levosimendan was associated with improved haemodynamics in patients with stable chronic HF, but we could not identify any predictors of the magnitude of haemodynamic response.
| Reference Key |
e2018eschaemodynamic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Najjar E;Stålhberg M;Hage C;Ottenblad E;Manouras A;Haugen Löfman I;Lund LH;; |
| Journal | ESC heart failure |
| Year | 2018 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
non-u.s. gov't
female
male
middle aged
Prospective Studies
Randomized Controlled Trial
follow-up studies
dose-response relationship
drug
intravenous
infusions
hemodynamics / drug effects
heart failure / drug therapy*
cardiotonic agents / administration & dosage
heart failure / physiopathology
pmid:29469177
pmc5933961
doi:10.1002/ehf2.12272
emil najjar
marcus stålhberg
lars h lund
hemodynamics / ethics*
simendan / administration & dosage*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.